| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $86.5M | +1024.8% |
| R&D Expense | $356.2M | +9.2% |
| SG&A Expense | $274.5M | +20.6% |
| Operating Income | -$579.8M | -6.0% |
| Pre-tax Income | -$541.5M | -1.6% |
| Net Income | -$541.5M | -1.6% |
| EPS (Basic) | -$9.05 | -0.8% |
| EPS (Diluted) | -$9.05 | -0.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $71.0M | -56.4% |
| Short-term Investments | $682.2M | -38.5% |
| Accounts Receivable | $83.0M | +507.7% |
| Current Assets | $869.4M | -35.0% |
| Total Assets | $882.3M | -35.0% |
| Current Liabilities | $82.7M | -16.6% |
| Total Liabilities | $82.7M | -20.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$540.6M | -17.5% |
| Capital Expenditures | $553K | -41.0% |
| Investing Cash Flow | $442.9M | +36.1% |
| Financing Cash Flow | $6.0M | +96.3% |
| Free Cash Flow | -$541.1M | -17.4% |
| Stockholders' Equity |
| $799.5M |
| -36.2% |